Hereditary Breast and Ovarian Cancer--From the Gynecological Viewpoint
Ohsumi, S.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(2): 189-192
2016
ISSN/ISBN: 0385-0684 PMID: 27093729 Document Number: 687048
Document emailed within 1 workday
Related Documents
Van der Linden, M.H. 2000: Psychosocial counseling after diagnosis for non-carriers of hereditary breast cancer or ovarian cancer; is it needed? Nederlands Tijdschrift Voor Geneeskunde 144(50): 2381-2384Levin, T.; Reichelt, J.; Heimdal, K.; Møller, P. 2001: Information to families with hereditary breast and ovarian cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(28): 3292-3294
Levine, D.A.; Gemignani, M.L. 2003: Prophylactic surgery in hereditary breast/ovarian cancer syndrome Oncology 17(7): 932
Seeber, B.; Driscoll, D.A. 2004: Hereditary breast and ovarian cancer syndrome: should we test adolescents? Journal of Pediatric and Adolescent Gynecology 17(3): 161-167
Foulkes, W.D.; Narod, S.A. 1995: Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing Clinical and Investigative Medicine. Medecine Clinique et Experimentale 18(6): 473-483
Cierniková, S.; Tomka, M.; Kovác, M.; Stevurková, V.; Zajac, V. 2006: Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families Neoplasma 53(2): 97-102
Lerman, C.; Narod, S.; Schulman, K.; Hughes, C.; Gomez-Caminero, A.; Bonney, G.; Gold, K.; Trock, B.; Main, D.; Lynch, J.; Fulmore, C.; Snyder, C.; Lemon, S.J.; Conway, T.; Tonin, P.; Lenoir, G.; Lynch, H. 1996: BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes JAMA 275(24): 1885-1892
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Kimura, E.; Murae, M.; Koga, R.; Odawara, Y.; Nakabayashi, Y.; Yokoyama, K.; Nakata, H.; Totake, T.; Ochiai, K.; Yasuda, M. 1984: Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 36(11): 2121-2128
Friedenson, B.; Friedenson, H. 2002: Genetic testing for breast and ovarian cancer for women with a family history of breast cancer: weighing conflicting evidence about oral contraceptives Medgenmed: Medscape General Medicine 4(3): 3
Hetzel, H.; Bichler, A.; Fuchs, D.; Hausen, A.; Reibnegger, G.; Wachter, H. 1983: Significance of urinary neopterine in gynecological oncology: follow-up of patients with ovarian cancer Cancer Detection and Prevention 6(1-2): 263-266
Krommer, K. 1992: Treatment of patients with advanced ovarian cancer at the Gynecological Clinic of Pécs Medical University Orvosi Hetilap 133(19): 1151-1158
Saho, M.; Ito, A.; Hiraki, T.; Ushijima, K. 2014: Anesthetic management of a patient with Trousseau's syndrome and ovarian cancer who underwent gynecological surgery Masui. Japanese Journal of Anesthesiology 63(11): 1257-1260
Jacobs, I.J.; Smith, S.A.; Wiseman, R.W.; Futreal, P.A.; Harrington, T.; Osborne, R.J.; Leech, V.; Molyneux, A.; Berchuck, A.; Ponder, B.A. 1993: A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus Cancer Research 53(6): 1218-1221
Menkiszak, J.; Górski, B.; Jakubowska, A.; Gronwald, J.; Huzarski, T.; Byrski, T.; Foszczyńska-Kłoda, M.łg.; Fliciński, J.; Brzosko, M.; Rzepka-Górska, I.; Lubiński, J. 2002: Clinical characteristics of hereditary ovarian cancer (HOC) in Poland Ginekologia Polska 73(9): 733-739
Genton, C.Y. 1990: Breast cancer: the pathologist's viewpoint Revue Medicale de la Suisse Romande 110(4): 307-310
Siegel, A.J. 1977: Detection of breast cancer. A practitioner's viewpoint Primary Care 4(4): 755-760
Blackman, K.E.; Fingert, H.J.; Fuller, A.F.; Meitner, P.A. 1994: The fluorescent cytoprint assay in gynecological malignancies and breast cancer. Methodology and results Contributions to Gynecology and Obstetrics 19: 53-63
Plu-Bureau, G. 1995: Oral contraception and risk of cancer. Epidemiological aspects of breast and gynecological cancers La Revue du Praticien 45(19): 2441-2444
Díez Gibert, O.; Machuca Cordano, I.; Navarro, M.A. 1998: Hereditary cancer of the breast and ovary Medicina Clinica 110(5): 199